Clinical Data Management

overview

CLINICAL DATA MANAGEMENT (CRO)

At Solvdata we believe in providing high quality clinical data management to support your drug development needs to get drugs to market as quickly as possible. We provide bespoke solutions tailored to your requirements and provide real time, faster access to data meaning faster decisions can be made to keep patients as safe as possible. As a niche data-focused CRO, our expertise allows us to focus solely on the data of a clinical trial and enables us to develop trust with long lasting partnerships.

By concentrating exclusively on data we are able to offer efficient and flexible clinical data management services, we are seen as a niche provider for smaller teams or a valuable experienced partner for larger accounts. Our programming team’s diverse backgrounds and abilities allow us to handle difficult or non-standard studies with ease. Solvdata’s data management services include efforts prior to conducting a study as well as ongoing PK/PD-focused support during study conduct by our team of data managers. Your data are crucial. Data is the language through which sponsors communicate information about investigational drugs to regulatory authorities. All too often during clinical conduct, the importance of data are minimized and overlooked. Or, the nuances of collection, reporting, and querying of data are not fully appreciated by investigational sites.

What to Expect During the Study Design Phase:

In the study design phase, Nuventra works with your team to craft a well designed Phase 1 study that contributes to your drug development plan. Our experts evaluate regulatory feedback and your current drug program to identify any clinical gaps and assist in generating a study overview that adequately addresses your needs for the study, with a focus on pharmacokinetics, safety, and other potential pharmacometric endpoints.

Our experts have a broad depth of experience and can provide as much or as little assistance as is needed, including writing the protocol, generating regulatory compliant data sets, and submitting all data to the FDA.

Solvdata provides end to end comprehensive clinical data management services from Phase I through to post-marketing trials. Our team of global clinical data management experts are committed to upholding a standardized, process-driven approach.

Our Clinical Data Management Services include:

  • On-shore and off-shore Clinical Data Management Services
  • EDC and Paper Trial Set-Up & Management
  • Certified Medidata RAVE Builders
  • Clinical Research Monitor Training for PK/PD Issues
  • Biostatistics/Bioequivalence/Bioavailability
  • Access to other EDC solutions (Low Cost, Oracle etc.)
  • Data Management Plan (DMP) development
  • Data Management Project Management
  • CRF/eCRF design and development
  • CRF Annotation & Review
  • Database Build & Design
  • Data validation specifications
  • Edit checks Programming & Testing
  • Data processing through double data entry
  • Query Management
  • Medical Coding
  • Safety Data Management & Reconciliation
  • Data Export/Transfer
  • CDASH Compliant deliverables
  • Dataset Generation for Population PK/PD Studies
  • Full CDISC Package Generation
  • Interim PK/PD Data Review
  • Mock Dataset Generation Prior to Database Lock
  • PK Sampling Schedule Review
  • PK/PD Data Management Plan Addendum
  • PK/PD Data Review Tactics
  • Protocol and Study Design Review
  • Review of Electronic Edit-Checks for PK/PD Data
Years experience

0+

Years experience
Certified experts

0

Certified experts
End user satisfaction

0%

End user satisfaction
Global reach

0countries

Global reach
Service desk

024/7

Service desk
Solvdata's

Non - Clinical Goals

  • Nonclinical to IND

    Solvdata’s nonclinical goal is to efficiently move our clients’ compound into the clinic. We apply the smartest tools and strategies for attaining a successful IND and entering the clinic with a strong rationale for the first-time-in-human dose.

     

    PK/PD/TK
    Noncompartmental Analysis
    GLP and Non-GLP
    Submission Ready Study Reports
    Regulatory, Writing & Strategy
    Nonclinical and Clinical Development Plans
    Advice and Design of IND-enabling Studies.

     

    IND Authoring (full or sections), Review, Publishing & Submission (CTD / eCTD)
    Regulatory Agency RFIs, Meetings, Planning & Representation
    Guidance Document Interpretation
    PopPK, Modeling & Simulation
    Model Based Drug Development
    Candidate Selection
    Allometric Scaling
    Predict Human Exposure
    Exposure Response
    Dose Selection, Justification
    Study Design Simulations
    Vendor Identification & Management
    Bio-analytical
    Pharmaceutical Development
    Toxicology

  • Early Phase

    There is much more to early phase development than simply checking off required studies. We work with clients to create plans that ensure each early phase study fits into your overall drug development program. Before starting any clinical study, we ask: How do these studies fit into the overall drug development strategy? How can clinical pharmacology data support late phase, efficacy and pivotal study success? What other data will be required to support the submission?

     

    PK/PD/TK
    Noncompartmental Analysis
    GLP and Non-GLP
    Submission Ready Study Reports
    PopPK, Modeling & Simulation
    Population PK Analysis
    Exposure Response
    Dose Selection, Justification
    Study Design Simulations
    Regulatory, Writing & Strategy
    Gap Analysis/QBR
    Clinical Pharmacology Plan
    Study Protocol
    Regulatory Agency RFIs, Meetings, Meeting Requests, Planning, Briefing Packet Preparation, Representation
    Clinical Operations
    Study Design and Conduct
    Site Qualification
    Data Fidelity/CDISC
    Vendor ID/Management
    Biostatistics

  • Late Phase

    Solvdata utilizes innovative modeling and simulation techniques to ensure that your program is ready for the approval process. Our Pharmacometricians ensure justification of dose for the marketplace, and author reports to detail their findings. We can use modeling and simulation to avoid certain late phase studies, scale to pediatrics, simulate entire studies, and more.

     

    PK/PD/TK
    Noncompartmental Analysis
    GLP and Non-GLP
    Submission Ready Study Reports
    PopPK, Modeling & Simulation
    Population PK Analysis
    Identify/Confirm Predictive Covariates
    Dose Selection, Justification
    Comparator Analysis
    Study Simulations
    Exposure Response
    Concentration QT
    Model Risk
    Large-scale NONMEM

  • NDA/BLA

    Solvdata has considerable experience with regulatory agencies around the globe. We work with our clients and the regulatory agencies to ensure that all documents are robust, insightful, scientifically focused and practical. You have invested significant resources to reach this point, contact the experts at Solvdata to ensure your submissions and/or strategic responses are well received by the agencies.

     

    Regulatory, Writing & Strategy
    Gap Analysis/QBR
    Guidance Document Interpretation
    NDA/BLA (Full or Sections)
    NDA/BLA Publishing and Submission (CTD/eCTD)
    Regulatory Agency RFIs, Meetings, Meeting Requests, Planning, Briefing Packet Preparation, Representation

At Solvdata, we help carry all expected and unexpected I.T burdens in your organisation so you can focus on growth.